Whether you are ready to schedule an appointment or just want some questions answered, we are here to help. Take the next step to a better life.

CBD: The Little Chemical That Could

Thanks to recent studies on the medicinal benefits of cannabidiol, or CBD, we have uncovered a vast amount of information on its amazing healing properties. CBD, a chemical component of almost all marijuana strains, has been proven to combat anxiety, chronic pain, vomiting, inflammation and convulsions, as well as slow or even terminate advancement of cancerous cells. Schizophrenia has even been shown to be treatable by CBD in rare cases. The biggest challenge in the widespread distribution of CBD, however, is the inability of many researchers to perform a complete set of trials and research due to stonewalling in the federal government.

Though CBD does not contain compounds that can cause severe narcotic effects, there does still exist effectual changes between high- and low-CBD strains of cannabis. If the strain contains any amount higher than 2%, it will usually create a feeling of relaxation and peace, acting as a reliable sleeping aid for anxiety-induced patients.  Most of these high-CBD varieties are also indica/indica-dominant, and easier for personal growing than many other strains.

Typically, 420 doctors and physicians will recommend selecting a variety with a moderate amount of THC while retaining a high amount of CBD. This is to minimize the standard disorienting effects of THC while still possessing the soothing powers of CBD. Research is currently underway at Temple University in Philadelphia to learn more about CBD’s benefits and effects, and has thus far confirmed general knowledge of the chemical’s power. However, testing on lab mice has also revealed that CBD has the ability to soothe pain caused by the chemotherapy treatment paclitaxel.  Sara Jane Ward, lead study author and research assistant professor for the Temple University School of Pharmacy, states, “From what we’ve seen so far, it’s almost a complete prevention of the onset of neuropathic pain.” Yet a few of the scientists were unfortunately unable to conduct a complete series of tests and studies due to marijuana’s status as a Schedule 1 controlled substance via federal law (including all of its components).